StonvexLoading…
StonvexStonvexStonvexCore line items from IHRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.86B | $3.85B | $3.75B | $3.91B |
Operating Income | $-20.64M | $-763.11M | $-797.31M | $56.86M |
Net Income | $-472.87M | $-1.01B | $-1.10B | $-264.66M |
EPS (Diluted) | $-3.06 | $-6.68 | $-7.39 | $-1.79 |
Total Assets | $5.13B | $5.57B | $6.95B | $8.34B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $270.92M | $259.58M | $346.38M | $336.24M |
Free Cash Flow OCF − CapEx | $10.91M | $-26.16M | $110.39M | $259.11M |
Shares Outstanding | 154.29M | 151.27M | 150.75M | 148.96M |